PDF Cover

Bronchoscopes Market

The market for Bronchoscopes was estimated at $1.1 billion in 2025; it is anticipated to increase to $1.7 billion by 2030, with projections indicating growth to around $2.4 billion by 2035.

Report ID:DS1801065
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Bronchoscopes
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Bronchoscopes Market Outlook

Revenue, 2025

$1.1B

Forecast, 2035

$2.4B

CAGR, 2026 - 2035

7.9%

The Bronchoscopes industry revenue is expected to be around $1.1 billion in 2026 and expected to showcase growth with 7.9% CAGR between 2026 and 2035. The growing demand for diagnostic and treatment procedures of lung conditions will be a significant factor in the growth of the bronchoscope market. The increased frequency of lung diseases such as COPD and lung cancer is also contributing to this trend. In this environment the division of 100% is between diagnostic and therapeutic applications of the equipment, indicating the vital position bronchoscopes hold in both the early detection of diseases and in interventional pulmonology procedures. Flexible bronchoscopes brought in a revenue of $0.87 billion in the year 2025, they also signify the trend of a changeover to more flexible and navigable pulmonary instruments for complex airways, used in ICUs, endoscopy units and operating rooms. Advances in technology will help keep bronchoscopes relevant to global medical treatment techniques. Bronchoscopes are flexible or rigid tubes with a camera and light on the end which enable doctors to see down patients airways and to perform various procedures through the instrument. Current practice is dominated by flexible bronchoscopes due to the advantages they offer over rigid models in terms of patient comfort and the bronchoscopes flexibility.

However rigid bronchoscopes remain crucial for selected therapeutic procedures. These include dealing with severe blockages in the airways and the removal of foreign bodies. Diagnostic applications encompass procedures for the collection of tissue samples, evaluation of infections, and lung cancer diagnosis. Treatment procedures involve bronchial hygiene necessary for the management of conditions such as COPD, stent placement and also biopsy. The increasing use of flexible bronchoscopes is due to several factors, including the growing use of either single use or hybrid bronchoscopes, their integration with imaging systems and navigation tools which helps pulmonologists during interventions, and the expanding use of these tools in outpatient and intensive care settings.

Bronchoscopes market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Bronchoscopes Market Outlook

Market Key Insights

  • The Bronchoscopes market is projected to grow from $1.1 billion in 2025 to $2.4 billion in 2035. This represents a CAGR of 7.9%, reflecting rising demand across Lung Diagnosis and Biopsy, Airway Management, and Bronchial Therapies.

  • Major firms such as Boston Scientific, Fujifilm Holdings and Karl Storz are instrumental in moulding the present market trends.

  • The U.S. and China will be the prime regions in the bronchoscopes market with expected compound annual growth rates between 2025 and 2030 of 5.1% and 7.6% respectively.

  • The countries that are expected to grow the most are India, Brazil and South Korea with growth rates between 9.1% and 10.9% per year.

  • The growth of flexible bronchoscopes will be driven by disposable technology, leading to a significant market expansion by 2030, valued at $123 million.

  • The bronchoscopes market is expected to expand by $1.3 billion between the years 2025 and 2035. The sector catering to therapeutic procedures is one region where suppliers are anticipated to gain more market share.

  • The respiratory disease incidence is set to drive a 114% increase in demand for bronchoscopes by 2035, as the quality of the products improves.

bronchoscopes market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Bronchoscopes - Country Share Analysis

Opportunities in the Bronchoscopes

Interventional pulmonology services are also being expanded in respiratory clinics across Western Europe, which has given rise to a considerable need for advanced bronchoscopes that are capable of supporting various procedures. Healthcare facilities are incorporating new technologies such as navigation systems, high resolution imaging, and tools for performing certain lung procedures. Flexible bronchoscopes which have greater working channels and higher maneuverability are likely to increase in demand. Rigid bronchoscopes are likely to continue being used in emergency procedures and thoracic surgery due to difficulties in accessing the airway.

Growth Opportunities in North America and Asia Pacific

Growing demand in North America for bronchoscopes is primarily driven by therapeutic applications, such as the management of lung cancer, severe COPD and complex airway stenosis where interventional procedures are performed. There is the greatest demand for advanced video bronchoscopes, hybrid systems and for single use bronchoscopes. These products integrate high definition imaging with both biopsy tools and navigation systems. This means there is the greatest demand for these in hospitals that specialise in cancer treatment and large teaching hospitals. The key opportunities in this region include the expansion of bronchoscopy platforms capable of various procedures, integrating AI assisted imaging to characterise lesions and teaming up with hospitals to standardise bronchoscopy equipment across multi site health care systems. In the high end sector of the market the competition is fierce, with leading global firms employing product innovation in region's such as flexible bronchoscopes and infection control, and also the offering of bespoke service packages. The mid tier firms have meanwhile sought to capitalise on the growth of outpatient surgery centres with their range of cost effective products. Regional market dynamics are characterised by a high incidence of chronic respiratory diseases, a reimbursement environment that is supportive for the cost saving benefits of minimally invasive techniques, a strict infection control regime favouring the use of equipment which is disposable, and a high rate of adoption of best practice bronchoscopy techniques which ensures rapid replacement of rigid bronchoscopes which are outdated and legacy systems.
In the Asia Pacific region, the demand for bronchoscopes is largely driven by diagnostic procedures. High numbers of patients undergo tests for tuberculosis, pneumonia, and other lung conditions, with a particular increase observed in rapidly urbanising countries. The market for bronchoscopes is growing with the increasing use of flexible bronchoscopes and fiber optics bronchoscopes, as well as lower-cost video bronchoscopes. Hospitals, both public and private, are replacing older systems with new bronchoscopy technologies that increase the number of tests that can be performed. Business opportunities include offering a tiered range of products tailored to smaller hospitals, building or producing locally to make devices more affordable, and implementing partnership programs that provide training to doctors. The market is made up of both multinational companies and local businesses, which are rapidly expanding. Demand for reusable and durable fiber optics bronchoscopes is driven by price-sensitive bids, while single-use bronchoscopes are selectively used in high-risk infection situations. Growth is supported by the expansion of respiratory care services, high healthcare costs, the need for early diagnosis of lung conditions, and an increasing number of trained pulmonary professionals.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Respiratory Diseases and Growing Demand for Minimally Invasive Diagnostic Procedures

The bronchoscope market is also propelled by the increasing prevalence of respiratory diseases, including lung cancer, COPD, tuberculosis, and asthma, along with a growing preference for minimally invasive diagnostic procedures. Globally, lung cancer remains one of the leading causes of cancer‑related deaths, while chronic respiratory conditions continue to rise due to aging populations, pollution, and smoking habits, driving the need for early and accurate diagnosis. Bronchoscopes, especially flexible video bronchoscopes, provide detailed visualization of the airway and facilitate biopsies without the extensive trauma associated with open surgical techniques. These devices help clinicians identify pathologies promptly and initiate treatment sooner, improving patient outcomes. At the same time, healthcare providers increasingly prioritize minimally invasive procedures that reduce hospital stays, lower complication rates, and provide faster recovery. As clinicians adopt advanced imaging technologies such as high‑definition imaging and narrow band imaging - the utility of bronchoscopes expands across diagnostic and interventional settings. Together, these trends fuel higher utilization of bronchoscopic procedures in hospitals and specialty clinics worldwide.
A key driver for bronchoscopes is also the advancement in high‑definition imaging, integration with therapeutic devices, and digital workflow solutions. Innovations such as enhanced optics, real‑time video visualization, accessory compatibility with cryotherapy and electrocautery devices, and digital recording tools enhance diagnostic precision and therapeutic efficacy. These technologies support complex interventions like tumor ablation, strictures management, and targeted biopsies, broadening bronchoscope applications and clinician adoption.
02

Restraint: High Costs and Reimbursement Challenges Limit Bronchoscope Adoption in Many Regions

The high acquisition and maintenance costs of advanced video bronchoscopes pose a significant restraint on market growth, especially in emerging and resource‑limited healthcare systems. Premium bronchoscopes with high‑definition imaging and therapeutic accessory compatibility are expensive to procure and service, discouraging smaller hospitals and clinics from investing. Limited insurance reimbursement for bronchoscopic procedures further suppresses demand, as patients may defer diagnostics or therapies, reducing procedure volumes and slowing revenue growth for manufacturers.
03

Opportunity: Growing adoption of single-use bronchoscopes for infection control in intensive care units across North America and Rapid expansion of bronchoscopy-guided lung cancer screening programs using flexible bronchoscopes across China and India

There is a shift in the North American hospitals infection control priorities, as they now focus on buying disposable bronchoscopes over reusable ones. This especially applies to ICUs that are caring for patients on ventilators. More and more procurement teams now take into account the total cost of ownership. This involves not only just the cost of reprocessing but also downtime and the risk of contamination. The global flexible bronchoscopes market, valued at $870m, is expected to reach $1.32bn by 2030. In comparison, the market for rigid bronchoscopes is predicted to increase from $260m to $330m by that year. This indicates that flexible disposable bronchoscopes will continue to be the fastest growing region of this market.
In countries with a high incidence of lung cancer such as China and India, hospitals are increasingly using bronchoscopes to facilitate the diagnosis of lung cancer. This is particularly true of large hospitals which have a bronchoscopy service. Across a number of countries there is a growing need for the early diagnosis of lung diseases due to worsening urban pollution and governments national plans for early detection. Rigid and flexible bronchoscopes will capture the majority of incremental sales. The flexible bronchoscope, capable of navigating the airways to the periphery of the lung, is equipped with capabilities to take biopsy samples and perform other diagnostic procedures.
04

Challenge: Infection Control Concerns and Complex Reprocessing Requirements Restrict Clinical Utilization

Strict infection control protocols and the complex, time‑intensive reprocessing requirements for reusable bronchoscopes hinder broader market adoption. Bronchoscopes necessitate meticulous cleaning, sterilization, and validation to prevent cross‑contamination, which increases operational burden and costs for healthcare facilities. Instances of device‑associated infections have prompted stricter regulatory scrutiny, deterring some facilities from high‑volume use. These challenges also drive interest in single‑use alternatives, but cost and waste concerns limit rapid uptake.

Supply Chain Landscape

1

Bronchoscopes Components

Corning IncorporatedSony CorporationHOYA Corporation
2

Bronchoscopes Manufacturing

Boston Scientific CorporationFujifilm Holdings CorporationKarl Storz GmbH
3

Bronchoscopes Distribution

Ambu A/SLymol MedicalMedline Industries
4

Bronchoscopes Clinical Applications

HospitalsPulmonology ClinicsAirway Management
Bronchoscopes - Supply Chain

Use Cases of Bronchoscopes in Lung Diagnosis & Biopsy

Lung Diagnosis and Biopsy : In lung diagnosis and biopsy procedures, flexible video bronchoscopes are widely used to visualize the tracheobronchial tree and collect tissue samples from suspicious lesions or nodules. These bronchoscopes offer high‑resolution imaging and maneuverability, enabling pulmonologists to precisely navigate airways and perform targeted biopsies with minimal patient discomfort. Their advantages include real‑time visualization and compatibility with advanced imaging tools such as narrow band imaging to improve diagnostic accuracy. Leading players such as Olympus, Karl Storz, Boston Scientific, and Fujifilm dominate this application with robust product portfolios that combine superior optics, ergonomic design, and integrated image capture. Hospitals and specialized respiratory clinics prefer these brands for their reliability, service support, and commitment to innovation, supporting early detection of lung cancers and other pulmonary diseases.
Airway Management : For airway management, rigid bronchoscopes and specialized flexible scopes with enhanced suction channels are frequently utilized to secure and maintain clear airway passages, particularly in emergency and critical care settings. Rigid bronchoscopes are preferred in cases requiring removal of large obstructions or foreign bodies due to their stability and superior instrumentation access, while flexible endoscopes aid in routine airway assessments and clearance of secretions. Providers such as Medtronic, Karl Storz, and Olympus deliver airway management solutions that emphasize durability, ease of sterilization, and compatibility with ventilation systems. Their strengths lie in clinician training support, extensive distribution networks, and trusted performance in operating rooms and intensive care units, ensuring patient safety and effective respiratory care delivery.
Bronchial Therapies : In bronchial therapies, advanced therapeutic flexible bronchoscopes integrated with channels for laser, electrocautery, and cryotherapy tools are essential for treating tumors, strictures, and bleeding lesions. These scopes enable targeted therapeutic interventions with minimal invasiveness, reduced procedural time, and faster patient recovery compared to open surgery. Key participants like Boston Scientific, Fujifilm, Olympus, and Pentax Medical lead this segment by offering multifunctional bronchoscopes with high‑definition imaging and accessory compatibility. Their products provide clinicians enhanced control and precision in delivering bronchial therapies, reinforcing these companies’ market positions through ongoing innovation and clinical validation across tertiary care centers and pulmonary specialty hospitals.

Recent Developments

Recent developments in the bronchoscope market reflect a strong shift toward advanced imaging and digital interventional technologies that enhance diagnostic accuracy and therapeutic capabilities. Key players are integrating high‑resolution video imaging, 3D visualization, and optical coherence tomography into flexible bronchoscopes, improving early detection of lung diseases and precision in biopsy and bronchial therapy procedures. A major market trend is the adoption of single‑use bronchoscopes to address infection control and streamline reprocessing workflows, expanding utilization in critical care and outpatient settings. These innovations support better clinical outcomes and are reshaping competitive dynamics across pulmonary care solutions.

March 2024 : Ambu’s aScope 5 Broncho single‑use bronchoscope family received CE mark and continued regulatory clearances, with smaller sizes and portfolio expansion throughout 2023 for pulmonology applications, indicating ongoing market activity and broader adoption.
September 2025 : Olympus Corporation introduced its advanced EBUS bronchoscope BF‑UCP190F with enhanced maneuverability and imaging for deeper lung diagnostics, expanding its presence in Europe and Asia‑Pacific markets. 
May 2024 : Olympus Corporation launched two bronchoscopes integrated with the EVIS X1 Endoscopy System, featuring advanced imaging and slim design for improved lung access. 

Impact of Industry Transitions on the Bronchoscopes Market

As a core segment of the Medical Device industry, the Bronchoscopes market develops in line with broader industry shifts. Over recent years, transitions such as Shift to Disposable Bronchoscopes and Emergence of Advanced Imaging Technology have redefined priorities across the Medical Device sector, influencing how the Bronchoscopes market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift to Disposable Bronchoscopes

The move away from reusable towards disposable bronchoscopes is transforming the medicalindustry'sview of the global bronchoscope market from one of cost to a model focused on minimising risk and delivering value. By 2030, this trend alone is likely to boost the industry by $123 million. With growing stringent infection control measures, escalating costs and the complication of reprocessing, healthcare providers are choosing single use bronchoscopes over reusable ones. The implementation of this system should result in significant savings in healthcare costs. This can be achieved through lower capital outlays, reduced infrastructure requirements and sterilisation facilities, as well as a decrease in lost time, all of which can then be applied to an increase in operating theatre efficiency and workflow. Healthcare facilities are increasingly turning to disposable bronchoscopes as a way to meet their needs for safety and compliance, while also keeping costs down. As a result, the use of disposable bronchoscopes is becoming a key differentiator in the bronchoscopes market.
02

Emergence of Advanced Imaging Technology

The emergence of advanced imaging technology is transforming the bronchoscope market by enhancing diagnostic precision and procedural efficiency. Modern bronchoscopes now incorporate three‑dimensional imaging and Optical Coherence Tomography (OCT), allowing clinicians to visualize airway structures in high detail and perform more accurate biopsies and therapeutic interventions. This transition positively impacts pulmonology, thoracic surgery, and interventional radiology by reducing procedural complications and improving patient outcomes. For example, hospitals and specialty clinics using OCT‑enabled bronchoscopes can detect early-stage lung lesions and guide targeted therapies more effectively. The integration of these imaging technologies also drives innovation in medical device software, AI-assisted diagnostics, and imaging accessory development, fostering collaboration between bronchoscope manufacturers and digital health solution providers. As a result, adoption rates are expected to rise across tertiary care centers and research hospitals, supporting market expansion and encouraging investment in connected, precision-based respiratory care technologies.